About Us
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.
It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.
Tailored lung-related studies, leveraging human tissue samples
Utilizing human tissue samples to provide physiologically-relevant insights
Imaging techniques & biomarker analysis to evaluate changes
Bridge the gap between preclinical research and clinical outcomes
Collaborative discussion to understand research goals and objectives
Customized development of assay protocols tailored to your specific requirements
Prepare lung tissue samples according to designed protocol, ensuring optimal conditions
Evaluate drug efficacy, toxicity and mechanisms of action
Quantitative and qualitatitive analysis of data obtained, including measurement of cell responses
Comprehensive reporting of results, including data interpretation and recommendations
At AnaBios, we are redefining preclinical drug discovery with our cutting-edge human lung tissue services, featuring precision-cut lung slices (PCLS). Designed to closely replicate the complex architecture and cellular diversity of the human lung, our PCLS platform empowers researchers to explore pulmonary diseases like idiopathic pulmonary fibrosis (IPF) with unparalleled accuracy.
Unlike traditional models, AnaBios’ human PCLS technology retains native lung tissue structure, enabling the study of fibrosis pathways, extracellular matrix remodeling, and therapeutic interventions in a physiologically relevant environment. With the ability to simulate disease progression and test anti-fibrotic compounds, our platform offers a predictive, human-relevant model for translational research.
Our services are tailored to meet the unique needs of pharmaceutical scientists and drug developers, including the use of lung tissue from normal and diseased donors. This enables comprehensive insights into inter-individual variability and the development of personalized therapies. From high-content drug screening to targeted biomarker discovery, AnaBios provides the tools you need to advance lung research and accelerate breakthroughs in pulmonary health.
Partner with AnaBios today to leverage the power of human precision-cut lung slices and elevate your drug discovery pipeline. Contact us to learn how our innovative solutions can transform your research into actionable therapeutic strategies.
WHITE PAPER
This white paper introduces AnaBios’ innovative use of human precision-cut lung slices as a robust preclinical model for studying pulmonary fibrosis and testing anti-fibrotic therapies. It highlights the platform’s ability to retain human tissue architecture, providing physiologically relevant insights into disease mechanisms and therapeutic responses.
To inquire about products, services and pricing, please go to the ‘Contact Us’ page by clicking the button below.